- Home
- ARRY vs AUPH Comparison
ARRY vs AUPH Comparison
Compare ARRY & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARRY
- AUPH
- Stock Information
- Founded
- ARRY 1989
- AUPH 1993
- Country
- ARRY United States
- AUPH Canada
- Employees
- ARRY N/A
- AUPH N/A
- Industry
- ARRY Semiconductors
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- ARRY Technology
- AUPH Health Care
- Exchange
- ARRY Nasdaq
- AUPH Nasdaq
- Market Cap
- ARRY 855.4M
- AUPH 1.3B
- IPO Year
- ARRY 2020
- AUPH 1999
- Fundamental
- Price
- ARRY $6.74
- AUPH $8.77
- Analyst Decision
- ARRY Buy
- AUPH Strong Buy
- Analyst Count
- ARRY 22
- AUPH 3
- Target Price
- ARRY $12.61
- AUPH $10.33
- AVG Volume (30 Days)
- ARRY 5.7M
- AUPH 1.3M
- Earning Date
- ARRY 02-25-2025
- AUPH 02-13-2025
- Dividend Yield
- ARRY N/A
- AUPH N/A
- EPS Growth
- ARRY N/A
- AUPH N/A
- EPS
- ARRY N/A
- AUPH N/A
- Revenue
- ARRY $982,190,000.00
- AUPH $220,361,000.00
- Revenue This Year
- ARRY N/A
- AUPH $36.97
- Revenue Next Year
- ARRY $24.77
- AUPH $16.43
- P/E Ratio
- ARRY N/A
- AUPH N/A
- Revenue Growth
- ARRY N/A
- AUPH 38.72
- 52 Week Low
- ARRY $5.15
- AUPH $4.71
- 52 Week High
- ARRY $16.63
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- ARRY 60.13
- AUPH 45.91
- Support Level
- ARRY $5.80
- AUPH $8.89
- Resistance Level
- ARRY $6.13
- AUPH $9.31
- Average True Range (ATR)
- ARRY 0.36
- AUPH 0.34
- MACD
- ARRY 0.13
- AUPH -0.11
- Stochastic Oscillator
- ARRY 98.15
- AUPH 1.43
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.